Literature DB >> 8355667

Characterization of ligand and substrate specificity for the calcium-dependent and calcium-independent protein kinase C isozymes.

M G Kazanietz1, L B Areces, A Bahador, H Mischak, J Goodnight, J F Mushinski, P M Blumberg.   

Abstract

Analysis of [3H]phorbol-12,13-dibutyrate (PDBu) binding was performed with protein kinase C (PKC)-alpha, -beta 1, -gamma, -delta, -epsilon, -eta, and -zeta produced in Sf9 insect cells using the baculovirus expression system. With the exception of PKC-zeta, all of the PKC isozymes bound [3H]PDBu with high affinity (Kd < 1 nM), either in the presence or in the absence of calcium. Scatchard analysis using 100% phosphatidylserine vesicles revealed slightly lower affinity for the calcium-independent isozymes (PKC-delta, -epsilon, and -eta) than for the calcium-dependent isozymes (PKC-alpha, -beta, and -gamma). Competition for [3H]PDBu binding by different classes of PKC activators showed that 12-deoxyphorbol esters, mezerein, and octahydromezerein likewise possessed lower affinity for the calcium-independent isozymes. The mezerein analog thymeleatoxin was the most marked example, being almost 20-fold less potent for binding to PKC-epsilon and -eta than to PKC-beta 1. In contrast, the indole alkaloids (-)-indolactam V and (-)-octylindolactam V and the postulated endogenous activator 1,2-diacylglycerol bound with similar affinities to all of the PKC isoforms, suggesting that different residues/configurations in the binding sites of the different PKC isozymes might be involved in interaction with the pharmacophore of the activators. The seven PKC isozymes also showed clearly different substrate specificities with exogenous peptide and protein substrates. The heterogeneous behavior of the different members of the PKC family with ligands and substrates may contribute to the heterogeneity of PKC-mediated pathways at the cellular level.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8355667

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  56 in total

1.  Purification of a lipid-activated and Ca2+-independent protein kinase from the mantle tissue of Mytilus galloprovincialis Lmk.

Authors:  Luis Mercado; Asunción Cao; Ramiro Barcia; Juan Ignacio Ramos-Martínez
Journal:  Mol Cell Biochem       Date:  2002-04       Impact factor: 3.396

2.  Protein kinase C isoforms in the enteric nervous system.

Authors:  Daniel P Poole; Billie Hunne; Heather L Robbins; John B Furness
Journal:  Histochem Cell Biol       Date:  2003-06-13       Impact factor: 4.304

3.  Fluorescent-responsive synthetic C1b domains of protein kinase Cδ as reporters of specific high-affinity ligand binding.

Authors:  Nami Ohashi; Wataru Nomura; Tetsuo Narumi; Nancy E Lewin; Kyoko Itotani; Peter M Blumberg; Hirokazu Tamamura
Journal:  Bioconjug Chem       Date:  2010-12-22       Impact factor: 4.774

4.  Structural determinants of phorbol ester binding activity of the C1a and C1b domains of protein kinase C theta.

Authors:  Agnes Czikora; Satyabrata Pany; Youngki You; Amandeep S Saini; Nancy E Lewin; Gary A Mitchell; Adelle Abramovitz; Noemi Kedei; Peter M Blumberg; Joydip Das
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-01-06       Impact factor: 3.747

5.  Atypical protein kinase C activity is required for extracellular matrix degradation and invasion by Src-transformed cells.

Authors:  Elena M Rodriguez; Elizabeth E Dunham; G Steven Martin
Journal:  J Cell Physiol       Date:  2009-10       Impact factor: 6.384

6.  Highly potent, synthetically accessible prostratin analogs induce latent HIV expression in vitro and ex vivo.

Authors:  Elizabeth J Beans; Dennis Fournogerakis; Carolyn Gauntlett; Lars V Heumann; Rainer Kramer; Matthew D Marsden; Danielle Murray; Tae-Wook Chun; Jerome A Zack; Paul A Wender
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-28       Impact factor: 11.205

7.  The structural requirements for phorbol esters to enhance serotonin and acetylcholine release from rat brain cortex.

Authors:  L Iannazzo; P Kotsonis; H Majewski
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

8.  Rational design of drugs that induce human immunodeficiency virus replication.

Authors:  Dean H Hamer; Sven Bocklandt; Louise McHugh; Tae-Wook Chun; Peter M Blumberg; Dina M Sigano; Victor E Marquez
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Three distinct mechanisms for translocation and activation of the delta subspecies of protein kinase C.

Authors:  S Ohmori; Y Shirai; N Sakai; M Fujii; H Konishi; U Kikkawa; N Saito
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

10.  Evidence for a role of conventional protein kinase-C alpha in the control of homotypic contacts and cell scattering of HT-29 human intestinal cells.

Authors:  M D Llosas; E Batlle; O Coll; A Skoudy; M Fabre; A García de Herreros
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.